Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Debt / NOTE 3.500% 9/1
-
Market price (% of par)
-
185.97%
-
Total 13F principal
-
$401,095,000
-
Principal change
-
+$304,420,000
-
Total reported market value
-
$746,370,187
-
Number of holders
-
38
-
Value change
-
+$577,634,645
-
Number of buys
-
34
-
Number of sells
-
5
Institutional Holders of APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1 as of Q2 2021
As of 30 Jun 2021 APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1 had 38 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $401,095,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Allianz Asset Management GmbH, WOLVERINE ASSET MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), CITADEL ADVISORS LLC, D. E. Shaw & Co., Inc., MACKAY SHIELDS LLC, BAKER BROS. ADVISORS LP, WELLS FARGO & COMPANY/MN, LAZARD ASSET MANAGEMENT LLC, and LMR Partners LLP.
This table shows 38 bond principal holders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.